1¦W50·³¤k©Ê¡A¦³»ó¶ë»PºC©Ê»óª¢¯gª¬¹F3¦~¤§¤[¡A¦P®É¦³¤ÆÁw¼Ë»ó®÷¡A´¿±µ¨ü§Ü¥Í¯À¤Î»óµÄ¤ºÃþ©T¾JªvÀø¡A¦ý®ÄªG¤£¨Î¡A¨S·Q¨ì¤fµÄ¤ºµwÃE¤Î³nÃE¶¡¥X²{µLµh©Ê¼ìºÅ¡A¨Ã¦ñÀH¤W¼L®B¸~¤j¡C¨D¶E¥Ö½§¬ì¡A¥J²ÓÀ˵ø«áµo²{¡A¸Ó¼ìºÅ¦³¤j½d³ò°ò©³Ãa¦º¡A©PÃ䪺ÂIª¬¼ìºÅ¤]¦³ÃþÅÖºû¼Ë¤Àªcª«¡A¶EÂ_µo²{´c©Ê¸~½F¡C
ªL¤fªø©°Âå°|¥Ö½§¬ì¥DªvÂå®v§d©ú¿oªí¥Ü¡AÀˬdӮצå²Gµo²{¡A¯f±w¥þ¦å²y§C¤U±¡§Î¡A¦¹±¡ªp·¥¦³¥i¯à¬°¦å²y§]¾½²{¶H©Ò³y¦¨¡F³o¬O1ºØ¥Ñ©óµoª¢©Ê²ÓM¿E¯À¡A¥]¬A¤zÂZ¯À¡]interferon-£^¡^¡B¤¶¥Õ¯À¡]interleukin,IL-12,IL-18¡^¥H¤Î¥Ò«¬¸~½FÃa¦º¦]¤l¡]TNF-£\¡^¤W¤É¡A³y¦¨°©Åè¤Î¨ä¥L²O¤Ú¾¹©x¤¤¤@¨t¦Cªº¦å²y§]¾½¡C
§d©ú¿o±j½Õ¡A¦å²y§]¾½²{¶H©ó¯S©w¤À«¬ªº²O¤ÚÀù¤¤¬°¬Û¹ï±`¨£ªºªí²{¡C«áÄò¶i¦æ«I¤J©Êªº°©Åè¤Á¤ù¡B²O¤Ú¸¢¤Á¤ù¡B¤D¦Ü©óµwÃE¤Î³nÃE²Õ´¤Á¤ù¡A³£ÃÒ¹ê¤F¦¹¯f¨_¬°¡u²O¤Úµ²¥~¦ÛµM±þ¤âT²ÓM²O¤ÚÀù¡v¦X¨Ö¦å²y§]¾½²{¶H¡C
§d©ú¿o¸ÑÄÀ¡A²O¤Úµ²¥~¦ÛµM±þ¤âT²ÓM²O¤ÚÀù¡A¦b¨È¸Ç±Ú¸s¦³¸û°ªªºµo¥Í¤ñ²v¡A©ó¥xÆW¡B¨È¬w¥H¤Î¤¤«n¬ü¬w±`¨£¡C¸~½F±`¦ì©ó¤¤¶b½u¤Wªº»ó³¡²Õ´ªþªñ¡A¥e7¦¨¡Aµo¥Íì¦]»P¨È¬w±`¨£ªº°ª¦MÀI«¬EB¯f¬r¦³¬Û·í¤jªºÃö«Y¡C¯f¤H¦~¬ö¥§¡¬°54·³¡A¨k¤k¤ñ¨Ò¬°2¡G1¡A¦Ó5¦~ªº¾ãÅé¦s¬¡²v¬ù¬°3¦¨¡C
§d©ú¿o«ü¥X¡A¤fµÄ¤ºµwÃE¤Î³nÃEªºÃa¦ºªí²{¡A¦bÁ{§É¤W¦³³\¦h»Ý¶i¤@¨B±Æ°£ªº¯e¯f¡A¨ä¤@§Y¬°¸Ó¯f±wªí²{ªº¤fµÄ踱³¡P©R©Ê¦×ªÞ¸~¡C¼Æ¦~¶¡¡A¸Ó¯f±wÁÓÂà©ó¥|³B¨DÂå¡B¥ÎÃÄ¡A¦ý¦]¨ü©ó¸Ó¯e¯f¶EÂ_ªº§xÃø©Ê¡AÁö¦³¯gª¬ªº¶¡·²½w©M¡A«o©l²×µLªk½T¥ß´c©Ê¸~½Fªº¶EÂ_¨Ãµ¹¤©¿n·¥ªvÀø¡C
§d©ú¿o¸É¥R¡AÓ®×µo²{¥þ¨©Ê¨t²Î¯e¯f¡A¥H¤ÎÂåÀø¹ï¯f±wªº²Ó¤ß©M¥Î¤ß¡A°t¦Xªø©°ÂåÀøÅé¨t¦h±M¬ì¤§¶¡ªº³q¤O¦X§@¡A²×©ó¥¿½T¶EÂ_¨Ãµ¹¤©¬Û¹ïÀ³ªºªvÀø¡C¥O¤H±{±¤ªº¬O¡A¯f±w¤´©ó1Ó¤ë«á¤£¼Ä¯fÅ]ªººR´Ý¦Ó¯f³u¡C
Ó®×ÂåªvÂå¾Ç¬É¦U±M¬ì¶¡·¥¨ã¼vÅT¤Oªº³»¯Å´Á¥Z¡m·s^®æÄõÂå¾ÇÂø»x¡n¡]The New England Journal of Medicine¡^2020¦~7¤ë¦¬¿ý©óÁ{§ÉÂå¾Ç¼v¹³Ó®×³ø§i±MÄæ¡AÅý©Ò¦³¾\Ū¦¹Ó®×³ø§iªºÂå®v̳£¯à±q¤¤¦³©Ò¦¬Ã¬¡B¤@°_¾Ç²ß¦¨ªø¡C¡]³¯·qõ¡þ¥x¥_³ø¾É¡^
¡]¹Ï¡þªL¤fªø©°Âå°|´£¨Ñ¡^
¨Ó·½¡G»ó¶ëºC©Ê»óª¢ºtÅܤfµÄ¼ìÄê ¼L®B¸~¤j´NÂåµo²{´c©Ê¸~½F
¥X³B¡GNOW°·±d